A Study of Participants Undergoing Radial Head Replacement Using the DePuy Synthes Radial Head Replacement System for Partial Replacement of the Elbow Joint
Launched by DEPUY SYNTHES PRODUCTS, INC. · Jun 9, 2022
Trial Information
Current as of May 24, 2025
Withdrawn
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female - skeletally mature adult (aged 22 or older)
- • Participant, who in the opinion of the Investigator, is able to understand the purpose of the study and is willing to return for all the required post-operative standard of care follow-up visits and have their data collected
- • Participant who is willing to give voluntary, written informed consent to participate in this clinical investigation and authorize the transfer of his/her information to the Sponsor
- Any one of below:
- • Primary replacement after fracture of the radial head
- • Participant needing a partial radial head replacement for degenerative or post-traumatic conditions presenting pain, crepitation, and decreased motion at the radio-humeral and/or proximal radio-ulnar joint with: i) joint destruction and/or subluxation visible on x-ray and/or ii. resistance to conservative treatment
- • Symptomatic sequelae after radial head resection
- • Revision following failed radial head arthroplasty
- Exclusion Criteria:
- • Dislocations of radius on ulna that would not allow a radio-humeral articulation
- • Rheumatoid arthritis
- • Infection, sepsis, and osteomyelitis
- • Uncooperative participant or participant with neurologic disorders who is incapable of following directions, osteoporosis, metabolic disorders which may impair bone formation, osteomalacia, distant foci of infections which may spread to the implant site, rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
- • Participants with limited life expectancy due to significant medical co-morbidity
- • Presence of major vascular or major nerve injury (radial, ulnar, medial, musculocutaneous)
- • Women who are pregnant or lactating
- • Unable to comply with study requirements example, with maintaining follow-up
- • Individuals currently involved in any personal injury litigation, medical-legal or worker's compensation claims
- • Individuals that have participated in a clinical investigation with an investigational product (drug or device) in the last three months
- • Demented or unable to provide informed consent
- • Individuals, in the opinion of the Investigator, who are drug or alcohol abusers or have psychological disorders that could affect their ability to complete participant reported questionnaires or be compliant with follow-up requirements
About Depuy Synthes Products, Inc.
DePuy Synthes Products, Inc. is a leading global medical device company specializing in orthopedic and neuro products. As a subsidiary of Johnson & Johnson, DePuy Synthes focuses on innovative solutions for joint reconstruction, trauma, spinal surgery, and craniomaxillofacial procedures. Committed to advancing patient care, the company invests in research and development to deliver evidence-based solutions that enhance surgical outcomes and improve the quality of life for patients. With a robust portfolio of implants, instruments, and technologies, DePuy Synthes partners with healthcare professionals worldwide to address the evolving needs of the orthopedic community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Eugene, Oregon, United States
Falls Church, Virginia, United States
Glasgow, , United Kingdom
Patients applied
Trial Officials
DePuy Synthes Products, Inc. Clinical Trial
Study Director
DePuy Synthes Products, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials